| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |